<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Med Case Rep</journal-id><journal-id journal-id-type="iso-abbrev">J Med Case Rep</journal-id><journal-title-group><journal-title>Journal of Medical Case Reports</journal-title></journal-title-group><issn pub-type="epub">1752-1947</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39731186</article-id><article-id pub-id-type="pmc">PMC11681769</article-id><article-id pub-id-type="publisher-id">4936</article-id><article-id pub-id-type="doi">10.1186/s13256-024-04936-y</article-id><article-categories><subj-group subj-group-type="heading"><subject>Case Report</subject></subj-group></article-categories><title-group><article-title>Pulmonary infection caused by <italic>Tropheryma whipplei</italic>: a case report and review of the literature</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Shi</surname><given-names>Jianglong</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Ren</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Qiu</surname><given-names>Jiehui</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Wei</surname><given-names>Chunping</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Pan</surname><given-names>Dejin</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Xiang</surname><given-names>Tianxin</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Cheng</surname><given-names>Na</given-names></name><address><email>chengnah@sina.com</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05gbwr869</institution-id><institution-id institution-id-type="GRID">grid.412604.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 1758 4073</institution-id><institution>Jiangxi Medical Center for Critical Public Health Events, </institution><institution>The First Affiliated Hospital of Nanchang University, </institution></institution-wrap>Nanchang, 330052 Jiangxi People&#x02019;s Republic of China </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05gbwr869</institution-id><institution-id institution-id-type="GRID">grid.412604.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 1758 4073</institution-id><institution>Department of Infectious disease, </institution><institution>The First Affiliated Hospital of Nanchang University, </institution></institution-wrap>Nanchang, 330006 China </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05gbwr869</institution-id><institution-id institution-id-type="GRID">grid.412604.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 1758 4073</institution-id><institution>Department of Hospital Infection Control, </institution><institution>The First Affiliated Hospital of Nanchang University, </institution></institution-wrap>Nanchang, 330006 China </aff></contrib-group><pub-date pub-type="epub"><day>28</day><month>12</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>28</day><month>12</month><year>2024</year></pub-date><pub-date pub-type="collection"><year>2024</year></pub-date><volume>18</volume><elocation-id>613</elocation-id><history><date date-type="received"><day>10</day><month>9</month><year>2024</year></date><date date-type="accepted"><day>2</day><month>11</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1"><italic>Tropheryma whipplei</italic> pneumonia is an infrequent medical condition. The clinical symptoms associated with this disease are nonspecific, often resulting in misdiagnosis or missed diagnosis. Therefore, sharing and summarizing the experiences in the diagnosis and treatment of this disease can deepen global understanding and awareness of it.</p></sec><sec><title>Case presentation</title><p id="Par2">The patient is a 78-year-old married Han Chinese female who was admitted to the hospital after experiencing fever, dry cough, and fatigue for 4&#x000a0;days. A lung computed tomography scan revealed inflammatory exudation in the lower left lung, accompanied by pleural effusion. The bronchoalveolar lavage fluid was subjected to further analysis using metagenomic next-generation sequencing, which identified 41 genetic sequences associated with <italic>Tropheryma whipplei</italic>. Consequently, she was diagnosed with <italic>Tropheryma whipplei</italic> pneumonia. After initiating treatment with doxycycline and biapenem, the patient&#x02019;s symptoms showed significant improvement. Upon discharge, the patient continued treatment with a combination of doxycycline and hydroxychloroquine, which was discontinued after 4&#x000a0;days. At 12-month follow-up, the patient reported overall good health, with no symptoms of fever, cough, or any other discomfort.</p></sec><sec><title>Conclusion</title><p id="Par3"><italic>Tropheryma whipplei</italic> pneumonia is a rare condition with nonspecific symptoms. The application of metagenomic next-generation sequencing technology in pulmonary infections helps to rapidly identify rare pathogens, providing a solid foundation for precise and effective antibacterial treatment for patients.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd><italic>Tropheryma whipplei</italic></kwd><kwd>Whipple&#x02019;s disease</kwd><kwd>Pneumonia</kwd><kwd>Case report</kwd></kwd-group><funding-group><award-group><funding-source><institution>Science and Technology Research Project of the Education Department of Jiangxi Province</institution></funding-source><award-id>GJJ2200217</award-id><principal-award-recipient><name><surname>Shi</surname><given-names>Jianglong</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; BioMed Central Ltd., part of Springer Nature 2024</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par4">Whipple&#x02019;s disease is a rare multisystem chronic condition with an incidence of less than 1 in 1,000,000 [<xref ref-type="bibr" rid="CR1">1</xref>]. First described by George Whipple in 1907, the disease was initially believed to stem from a metabolic disorder owing to observed abnormalities in the digestive tract. However, with the advent of effective antibiotics and advancements in electron microscopy, it was later confirmed to be a bacterial infection. It was not until 2000 that the causative bacterium, <italic>Tropheryma whipplei</italic>, was successfully cultured [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. <italic>Tropheryma whipplei</italic> is a rod-shaped, Gram-positive bacterium, measuring approximately 2&#x000a0;&#x000b5;m in length and 0.25&#x02013;0.5&#x000a0;&#x000b5;m in diameter. It possesses a distinctive three-layered cell wall ultrastructure, as observed under electron microscopy, and is recognized as one of the slowest-growing human pathogens, with a generation time of approximately 18&#x000a0;days [<xref ref-type="bibr" rid="CR4">4</xref>]. Classic Whipple&#x02019;s disease primarily affects the gastrointestinal tract, presenting with diarrhea and weight loss [<xref ref-type="bibr" rid="CR3">3</xref>]. In recent years, cases of chronic localized and acute infections caused by this pathogen have been reported, including endocarditis, pulmonary infections, and ocular uveitis [<xref ref-type="bibr" rid="CR5">5</xref>&#x02013;<xref ref-type="bibr" rid="CR7">7</xref>]. These new manifestations differ from the classical symptoms of Whipple&#x02019;s disease and are more likely to lead to misdiagnosis or underdiagnosis. <italic>Tropheryma whipplei</italic> can cause either infection or colonization. In this case report, we describe a pulmonary infection caused by <italic>Tropheryma whipplei</italic> in an elderly female patient who presented with fever and a dry cough. Chest computed tomography (CT) revealed infectious lesions, but microbial cultures of sputum, blood, and bronchoalveolar lavage fluid (BALF) did not yield any identifiable pathogens. Fortunately, through next-generation metagenomic sequencing, we successfully identified <italic>Tropheryma whipplei</italic> in the BALF. Following targeted antimicrobial therapy, the patient&#x02019;s condition improved, leading us to classify this as an infection rather than mere colonization. Furthermore, given the limited reports on <italic>Tropheryma whipplei</italic> pneumonia in both domestic and international literature, we conducted a retrospective analysis to enhance healthcare professionals&#x02019; understanding of this disease.</p></sec><sec id="Sec2"><title>Case presentation</title><p id="Par5">The patient is a 78-year-old married Han Chinese woman who was admitted to the hospital with a fever, dry cough, and fatigue lasting 4&#x000a0;days. She developed a fever 4&#x000a0;days prior, reaching a maximum temperature of 39.9&#x000a0;&#x000b0;C, accompanied by paroxysmal dry cough, fatigue, and thigh muscle pain, without any chest tightness or pain. On the third day of her illness, she visited a local hospital, where a computed tomography (CT) scan of the chest revealed inflammatory exudate in the left lower lung along with pleural effusion (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>A). Despite receiving empirical antiinfective treatment with moxifloxacin and oseltamivir phosphate, she continued to experience fever. During her illness, her mental state and appetite declined compared with her baseline health. The patient has a history of cerebral infarction and has been taking atorvastatin calcium tablets long-term. Additionally, she has a history of anxiety, for which she has been receiving ongoing treatment with haloperidol and melitracen. She also has a history of drug allergies, specifically to cephalosporins, penicillins, and azithromycin. There were no notable abnormalities reported in her personal, marital, or menstrual history, nor in her family history.<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Chest computed tomography scan of the patient. The dates from left to right are 15 September 2021 (<bold>A</bold>), 23 September 2021 (<bold>B</bold>), and 29 September 2021 (<bold>C</bold>)</p></caption><graphic xlink:href="13256_2024_4936_Fig1_HTML" id="MO1"/></fig></p><p id="Par6">Upon admission, the patient&#x02019;s body temperature was 37.8&#x000a0;&#x000b0;C, with a heart rate of 103 beats per minute and a respiratory rate of 20 breaths per minute. Her blood pressure was recorded at 136/68&#x000a0;mmHg (1&#x000a0;mmHg&#x02009;=&#x02009;0.133&#x000a0;kPa). She appeared to be in poor mental state. Physical examination revealed a soft neck with no palpable enlargement of superficial lymph nodes. Auscultation of the lungs showed weak breath sounds bilaterally, but no significant rales were noted. The heart rate remained at 103 beats per minute, with a regular rhythm, and no murmurs were detected in any of the valve areas. The abdomen was soft, with no tenderness or pressure pain, and there was no edema in either lower extremity. Rebound tenderness was absent, bowel sounds were normal, and there was no swelling in the lower limbs. The patient was diagnosed with a pulmonary infection upon admission. Owing to the nonspecific nature of her symptoms, it is necessary to rule out other possibilities such as atypical pathogens, viral infections, and fungal infections when determining the causative agents of the pulmonary infection.</p><p id="Par7">On the second day of hospitalization, during the ward round, we auscultated the lungs and noted the presence of some wet rales. Additionally, we conducted multiple laboratory and imaging analyses. The elevated levels of C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) indicated a significant inflammatory response in the patient. The specific results are as follows:<list list-type="bullet"><list-item><p id="Par8"><bold>White blood cell count (WBC):</bold> 4.99&#x000a0;&#x000d7;&#x000a0;10<sup>9</sup>/L (reference range: 3.5&#x02013;9.5)</p></list-item><list-item><p id="Par9"><bold>Hemoglobin (HB):</bold> 93&#x000a0;g/L (130&#x02013;175)</p></list-item><list-item><p id="Par10"><bold>Platelets (PLT):</bold> 143&#x000a0;&#x000d7;&#x000a0;10<sup>9</sup>/L (125&#x02013;350)</p></list-item><list-item><p id="Par11"><bold>C-reactive protein (CRP):</bold> 105.41&#x000a0;mg/L (0&#x02013;8)</p></list-item><list-item><p id="Par12"><bold>Erythrocyte sedimentation rate (ESR):</bold>&#x000a0;65&#x000a0;mm/hour (0&#x02013;20)</p></list-item><list-item><p id="Par13"><bold>Procalcitonin (PCT):</bold>&#x000a0;0.15&#x000a0;ng/mL (&#x0003c;&#x02009;0.5)</p></list-item><list-item><p id="Par14"><bold>Interleukin-6 (IL-6):</bold>&#x000a0;187.58&#x000a0;pg/mL (0&#x02013;11.09)</p></list-item><list-item><p id="Par15"><bold>Alanine aminotransferase (ALT):</bold> 41&#x000a0;U/L (9&#x02013;50)</p></list-item><list-item><p id="Par16"><bold>Aspartate aminotransferase (AST):</bold>&#x000a0;47&#x000a0;U/L (15&#x02013;40)</p></list-item><list-item><p id="Par17"><bold>Albumin (ALB):</bold>&#x000a0;31&#x000a0;g/L (40&#x02013;55)</p></list-item><list-item><p id="Par18"><bold>Creatinine (CR):</bold>&#x000a0;52.6&#x000a0;&#x000b5;mol/L (57&#x02013;111)</p></list-item><list-item><p id="Par19"><bold>Potassium (K):</bold>&#x000a0;3.43&#x000a0;mmol/L (3.5&#x02013;5.3)</p></list-item><list-item><p id="Par20"><bold>Sodium (Na):</bold>&#x000a0;125.6&#x000a0;mmol/L (137&#x02013;147)</p></list-item></list></p><p id="Par21"><italic>Mycoplasma pneumoniae</italic> immunoglobulin M (IgM), <italic>Chlamydia pneumoniae</italic> IgM, respiratory syncytial virus IgM, adenovirus IgM, coxsackievirus group B IgM, plasma fungal-<sc>d</sc>-glucan, serum galactomannan, serum cryptococcal podococcal antigen, T-cell spot test for tuberculosis infection, tumor markers, urine and stool routine, coagulation function, electrocardiogram, and cardiac ultrasound were all normal. The thyroid ultrasound indicated bilateral lobar thyroid cysts, categorized as Chinese Thyroid Imaging Reports and Data Systems (C-TIRADS) 2. On the third day of hospitalization, bronchoscopy was performed, revealing a normal bronchial tree (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). Subsequently, bronchoalveolar lavage was conducted, and the BAL fluid (BALF) was sent for testing using metagenomic next-generation sequencing (mNGS) at the Department of Laboratory, The First Affiliated Hospital of Nanchang University. On the fourth day of hospitalization, mNGS detected 41 sequence reads of <italic>Tropheryma whipplei</italic>. Additionally, no pathogens were found in the previously collected sputum and blood cultures. On the eighth day of hospitalization, the microbiological culture of the bronchoalveolar lavage fluid showed no pathogen growth. On the basis of her clinical symptoms, lung CT findings, negative microbiological cultures, and mNGS results, she was diagnosed with a pulmonary infection caused by <italic>Tropheryma whipplei</italic>.<fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>Fiberoptic bronchoscopy of the patient: trachea carina (<bold>A</bold>), superior lobe of right lung (<bold>B</bold>), middle segmental bronchus of right lung (<bold>C</bold>), middle lobe of right lung (<bold>D</bold>), lower lobe of right lung (<bold>E</bold>), inherent superior lobe of left lung (<bold>F</bold>), and lingual lobe of left lung (<bold>G</bold>)</p></caption><graphic xlink:href="13256_2024_4936_Fig2_HTML" id="MO2"/></fig></p><p id="Par22">Upon admission, the patient was treated with a combination therapy consisting of biapenem (0.6&#x000a0;g, intravenous, every 12&#x000a0;h) and doxycycline hydrochloride tablets (100&#x000a0;mg, oral, every 12&#x000a0;h), supplemented with supportive measures such as nutritional supplementation and maintenance of electrolyte balance. As a result, her temperature stabilized, and both her mental and physical strength significantly improved, with a substantial reduction in coughing. On the eighth day of hospitalization, laboratory evaluations revealed a CRP level of 14.65&#x000a0;mg/L, an ESR of 39&#x000a0;mm/h, a PCT of&#x02009;&#x0003c;&#x02009;0.1&#x000a0;ng/mL, and an IL-6 level of 6.66&#x000a0;pg/mL. Liver and thyroid functions remained within normal limits, while chest CT scans demonstrated absorption of the infected lung lesions and a reduction in pleural effusion compared with previous scans (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>B). Given the slow resolution of lung inflammatory lesions, we conducted a thorough literature review on <italic>Tropheryma whipplei</italic> infections, considered alternative treatment options, and initiated hydroxychloroquine sulfate tablets (200&#x000a0;mg, oral, three times daily) on the 13th day. A follow-up chest CT on the 15th day showed further reduction in inflammatory lung lesions (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>C). Her temperature remained normal, coughing ceased, and her overall condition improved, leading to her discharge on the 16th day. Post discharge, she continued treatment with doxycycline hydrochloride tablets (100&#x000a0;mg, oral, every 12&#x000a0;h) and hydroxychloroquine sulfate tablets (200&#x000a0;mg, oral, three times daily) but discontinued self-administered treatment 4&#x000a0;days later. Her temperature remained normal without respiratory symptoms such as coughing or sputum production. The patient visited our outpatient clinic in late November 2021. A follow-up chest CT showed further reduction in pulmonary inflammatory lesions compared with 29 September 2021. In September 2022, during a telephone follow-up regarding her condition, the patient reported no discomfort and agreed to share her case publicly.</p><p id="Par23">We utilized the PubMed database to conduct a comprehensive literature review, focusing exclusively on English-language papers. The search encompassed a timeframe stretching from the inception of the database until 28 November 2022, utilizing the search formula &#x0201c;[(Tropheryma Whipplei) OR (Whipple&#x02019;s disease)] AND [(pneumonia) OR (Pulmonary infection)]&#x0201d;. Following the retrieval of articles, we meticulously reviewed the titles, abstracts, and full texts to exclude studies that were deemed irrelevant, retaining only those that unequivocally indicated pulmonary infection with <italic>Tropheryma whipplei</italic> for further scrutiny. Ultimately, eight studies met our criteria and were selected for analysis (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). As depicted in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>, these eight studies encompass a cumulative total of nine case reports involving pulmonary infections caused by <italic>Tropheryma whipplei</italic>. Among these nine patients, six were male and three were female, with ages spanning from 23 to 81&#x000a0;years. All patients exhibited respiratory-related symptoms, including cough and dyspnea, while five presented with fever and four suffered from weight loss. Diagnosis was established through polymerase chain reaction (PCR) and next-generation sequencing (NGS) tests on bronchoalveolar lavage fluid or via histological biopsy. Post diagnosis, the majority of patients underwent a switch to sensitive antibiotics, such as tetracycline, doxycycline, hydroxychloroquine, and sulfamethoxazole, resulting in immediate symptom improvement. Upon monitoring their subsequent condition changes from the time of diagnosis, we observed that eight patients had a favorable prognosis, whereas only one had an unfavorable outcome. Upon reviewing the medical history of this latter patient, it was noted that he was of advanced age, had a prior history of coronary stenting and hypertension, was in a poor baseline condition, and NGS analysis of bronchoalveolar lavage fluid indicated a mixed infection involving <italic>Tropheryma whipplei</italic> and <italic>Candida</italic> sp. However, when his condition deteriorated, he declined extracorporeal membrane oxygenation, ultimately leading to his demise despite aggressive treatment efforts.<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Studies of pulmonary inflammation caused by <italic>Tropheryma whipplei</italic></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Case</th><th align="left">Sex/age</th><th align="left">Past medical history</th><th align="left">Respiratory symptom</th><th align="left">Other symptom</th><th align="left">Diagnosis</th><th align="left">Treatment</th><th align="left">Follow-up* and outcome</th></tr></thead><tbody><tr><td align="left">Winberg CD [<xref ref-type="bibr" rid="CR8">8</xref>]</td><td align="left">M/52</td><td align="left">Colonic polyp</td><td align="left">Chronic cough</td><td align="left">Fever, diarrhea, weight loss</td><td align="left">Lung biopsy</td><td align="left">Tetracycline</td><td align="left">None</td></tr><tr><td align="left">Kelly CA [<xref ref-type="bibr" rid="CR9">9</xref>]</td><td align="left">M/31</td><td align="left">None</td><td align="left">Dry cough</td><td align="left">Weight loss, poor appetite</td><td align="left">Histological examination</td><td align="left">Penicillin, tetracycline</td><td align="left">19&#x000a0;months, good</td></tr><tr><td align="left">Fenollar F [<xref ref-type="bibr" rid="CR10">10</xref>]</td><td align="left">F/70</td><td align="left">Gallbladder removal, scoliosis, diarrhea</td><td align="left">Dyspnea</td><td align="left">Nocturnal sweats, fever, myalgia,arthralgia</td><td align="left">Lung biopsy and bronchoalveolar lavage fluid (PCR)</td><td align="left">Doxycycline, hydroxychloroquine</td><td align="left">8&#x000a0;months, good</td></tr><tr><td align="left">Stein A [<xref ref-type="bibr" rid="CR11">11</xref>]</td><td align="left">M/24</td><td align="left">AIDS</td><td align="left">Dry cough, dyspnea</td><td align="left">Fever, anorexia, asthenia, weight loss</td><td align="left">Bronchoalveolar lavage fluid (PCR)</td><td align="left">Cotrimoxazole</td><td align="left">2&#x000a0;weeks, good</td></tr><tr><td align="left">Wang S [<xref ref-type="bibr" rid="CR12">12</xref>]</td><td align="left">F/23</td><td align="left">none</td><td align="left">Chest distress, dyspnea</td><td align="left">Fever, bloody stools and headache, joint pain, weight loss</td><td align="left">Bronchoalveolar lavage fluid (NGS)</td><td align="left">Imipenem</td><td align="left">18&#x000a0;days, good</td></tr><tr><td align="left">Yan J [<xref ref-type="bibr" rid="CR13">13</xref>]</td><td align="left">M/28</td><td align="left">Pneumocystis pneumonia, AIDS</td><td align="left">Dry cough, polypnea, chest tightness</td><td align="left">None</td><td align="left">Bronchoalveolar lavage fluid (NGS)</td><td align="left">Sulfamethoxazole, meropenem</td><td align="left">16&#x000a0;days, good</td></tr><tr><td align="left">Zhu B [<xref ref-type="bibr" rid="CR14">14</xref>]</td><td align="left">M/44</td><td align="left">Diabetes, hepatitis C, intravenous drug use</td><td align="left">Dry cough, polypnea, chest tightness</td><td align="left">None</td><td align="left">Bronchoalveolar lavage fluid (NGS)</td><td align="left">Trimethoprim, sulfamethoxazole</td><td align="left">21&#x000a0;days, good</td></tr><tr><td align="left">Li W [<xref ref-type="bibr" rid="CR15">15</xref>], case 1</td><td align="left">F/39</td><td align="left">Cesarean section</td><td align="left">Cough, dyspnea</td><td align="left">Fever</td><td align="left">Bronchoalveolar lavage fluid (NGS)</td><td align="left">Sulfamethoxazole, meropenem</td><td align="left">17&#x000a0;days, good</td></tr><tr><td align="left">Li W [<xref ref-type="bibr" rid="CR15">15</xref>], case 2</td><td align="left">M/81</td><td align="left">Coronary stenting and hypertension</td><td align="left">Coughing, dyspnea</td><td align="left">None</td><td align="left">Bronchoalveolar lavage fluid (NGS)</td><td align="left">Sulfamethoxazole, meropenem</td><td align="left">2&#x000a0;days, poor</td></tr></tbody></table><table-wrap-foot><p><italic>M</italic> male, <italic>F</italic> female, <italic>NGS</italic> next-generation sequencing, <italic>PCR</italic> polymerase chain reaction, <italic>good</italic> good prognosis, <italic>poor</italic> poor prognosis, <italic>AIDS</italic> acquired immunodeficiency syndrome</p><p><sup>*</sup>The follow-up period for patients is counted from the time of diagnosis</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec3"><title>Discussion</title><p id="Par24">Whipple&#x02019;s disease is a multisystemic disorder, yet pulmonary involvement remains underreported. The cardinal clinical manifestations of lung involvement encompass cough, dyspnea, and chest pain, with CT scans revealing pulmonary nodules, interstitial alterations, and patchy infiltrates [<xref ref-type="bibr" rid="CR16">16</xref>]. Owing to the absence of specific diagnostic markers, Whipple&#x02019;s disease frequently goes unrecognized or misdiagnosed, often resulting in a delayed diagnosis. Prior to the advent of polymerase chain reaction (PCR) as a diagnostic tool, approximately 12 cases of classical Whipple&#x02019;s disease were identified annually worldwide based on duodenal biopsy studies, although the actual incidence is likely much higher [<xref ref-type="bibr" rid="CR17">17</xref>]. The current estimated global annual incidence ranges from 1 to 6 new cases per 10 million individuals [<xref ref-type="bibr" rid="CR17">17</xref>]. Diagnosis of Whipple&#x02019;s disease is challenging, with a median delay of over 6&#x000a0;years between the onset of initial symptoms and definitive diagnosis [<xref ref-type="bibr" rid="CR18">18</xref>]. Currently, tissue biopsy, particularly with Periodic acid&#x02013;Schiff (PAS) staining or immunohistochemical analysis of biopsy specimens, is widely regarded as the gold standard for diagnosing classical Whipple&#x02019;s disease. In contrast, PCR testing of bodily fluids serves as the primary basis for diagnosing limited chronic infections. Microbiological cultures and serological tests are not routinely employed owing to their lack of specificity in blood tests [<xref ref-type="bibr" rid="CR18">18</xref>]. In addition, in recent years, with advancements in microbial genetic testing technology, mNGS has played a significant role in diagnosing Whipple&#x02019;s disease infections. mNGS is a novel pathogen detection technology that offers high efficiency, a broad spectrum of pathogens, and high sensitivity. It is particularly suitable for detecting rare pathogens. Compared with traditional methods, mNGS has demonstrated superior diagnostic performance [<xref ref-type="bibr" rid="CR19">19</xref>]. However, mNGS also has notable shortcomings, such as its difficulty in distinguishing between pathogens and colonizing microorganisms. Additionally, the mNGS workflow is complex and involves multiple processes, which poses challenges to its widespread use. Apart from technical challenges, other factors limiting the broad implementation of mNGS include inadequate quality assurance, high costs, and considerations regarding sequencing depth [<xref ref-type="bibr" rid="CR20">20</xref>]. <italic>Tropheryma whipplei</italic> infection can lead to classic Whipple&#x02019;s disease, chronic localized infections, acute infections, and asymptomatic infections. The clinical symptoms of this disease are nonspecific, making it difficult for clinicians to detect. When patients present with frequent episodes of arthralgia, arthritis of large joints, seronegative polyarthritis, chronic diarrhea, malabsorption syndrome, abdominal pain, and unexplained weight loss, Whipple&#x02019;s disease should be considered, prompting targeted investigations [<xref ref-type="bibr" rid="CR21">21</xref>]. In terms of treatment, doxycycline combined with hydroxychloroquine constitutes an effective bactericidal regimen against <italic>Tropheryma whipplei</italic>, typically involving a 1-year course of doxycycline and hydroxychloroquine followed by lifelong doxycycline maintenance therapy. However, Whipple&#x02019;s disease is characterized by a high recurrence rate, with 30&#x02013;40% of patients experiencing relapses, necessitating regular monitoring. In the absence of clinical symptoms, biannual PCR monitoring of stool, saliva, and urine suffices [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. In reviewing the case we managed, we established a diagnosis of <italic>Tropheryma whipplei</italic> pneumonia based on the patient&#x02019;s symptoms (fever with dry cough), imaging findings suggestive of pulmonary infection, negative microbiological culture results, and pathogenic genetic testing from bronchoalveolar lavage fluid. During the treatment process, we empirically initiated a regimen of doxycycline combined with biapenem upon admission, which led to rapid alleviation of the patient&#x02019;s fatigue and dry cough, along with temperature control. This is consistent with the majority of reported diagnoses and treatment courses for Whipple&#x02019;s disease.However, despite a 10-day course of antiinfective therapy, the patient&#x02019;s lung CT showed minimal improvement in inflammation. At discharge, we adjusted the treatment plan to include doxycycline hydrochloride (100&#x000a0;mg, orally, every 12&#x000a0;h) and hydroxychloroquine sulfate (200&#x000a0;mg, orally, three&#x000a0;times daily). Unfortunately, the patient did not adhere to the treatment regimen and discontinued her medication on her own 4&#x000a0;days post discharge. Despite the short duration of treatment, 1&#x000a0;year later, the patient reported no respiratory symptoms such as fever or cough, which contrasts with previous studies suggesting a treatment duration of over 1 year. Classic Whipple&#x02019;s disease is a rare systemic condition typically characterized by weight loss, diarrhea, and arthralgia. Reports of acute pulmonary infections caused by <italic>Tropheryma whipplei</italic> are even rarer, and there are no large-scale clinical studies confirming the duration of therapy for Whipple&#x02019;s pneumonia. Notably, the patient we managed did not exhibit symptoms of weight loss, diarrhea, or arthralgia; thus, we considered her condition to be an acute pulmonary infection caused by <italic>Tropheryma whipplei</italic>. Although she discontinued her medication 4&#x000a0;days after discharge, the absence of symptom recurrence suggests that the treatment duration for acute pulmonary infections caused by <italic>Tropheryma whipplei</italic> may not be as prolonged as previously thought. Further research with larger sample sizes is needed to validate the treatment duration for acute infections caused by <italic>Tropheryma whipplei</italic>.</p></sec><sec id="Sec4"><title>Conclusion</title><p id="Par25">We report a rare case of pneumonia caused by <italic>Tropheryma whipplei</italic>. Whipple&#x02019;s disease is a systemic infectious disease caused by <italic>Tropheryma whipplei</italic> that may affect multiple systems throughout the body. Whipple&#x02019;s disease has a very low incidence and is difficult to diagnose. Metagenomic next-generation sequencing has good value in detecting <italic>Tropheryma whipplei</italic> infection.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>Not applicable.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>J.S. reviewed the literature and wrote the initial drafts of the manuscript; R.L., J.Q., C.W., D.P., T.X., and N.C. managed the patient, reviewed the literature, and contributed to the completion of the manuscript. All authors read and approved the final version of the manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Financial support was provided by Science and Science and Technology Research Project of the Education Department of Jiangxi Province (GJJ2200217).</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>The medical data used in this study are available upon reasonable request to the corresponding author.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par26">Taking into account that the patient&#x02019;s long-term residence is far away from our hospital, we have maintained telephone contact with the patient and her daughter, and the patient has agreed to allow us to publish her case.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par27">Written informed consent was obtained from the patient for publication of this report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par28">The authors declare that they have no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>T</given-names></name><name><surname>Moos</surname><given-names>V</given-names></name><name><surname>Loddenkemper</surname><given-names>C</given-names></name><etal/></person-group><article-title>Whipple's disease: new aspects of pathogenesis and treatment</article-title><source>Lancet Infect Dis</source><year>2008</year><volume>8</volume><issue>3</issue><fpage>179</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(08)70042-2</pub-id><pub-id pub-id-type="pmid">18291339</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Schneider T, Moos V, Loddenkemper C, <italic>et al</italic>. Whipple&#x02019;s disease: new aspects of pathogenesis and treatment. Lancet Infect Dis. 2008;8(3):179&#x02013;90.<pub-id pub-id-type="pmid">18291339</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Fenollar</surname><given-names>F</given-names></name><name><surname>Pu&#x000e9;chal</surname><given-names>X</given-names></name><name><surname>Raoult</surname><given-names>D</given-names></name></person-group><article-title>Whipple&#x02019;s disease</article-title><source>N Engl J Med</source><year>2007</year><volume>356</volume><issue>1</issue><fpage>55</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1056/NEJMra062477</pub-id><pub-id pub-id-type="pmid">17202456</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Fenollar F, Pu&#x000e9;chal X, Raoult D. Whipple&#x02019;s disease. N Engl J Med. 2007;356(1):55&#x02013;66.<pub-id pub-id-type="pmid">17202456</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Raoult</surname><given-names>D</given-names></name></person-group><article-title>From whipple disease to <italic>Tropheryma </italic>whipplei infection</article-title><source>Clin Infect Dis</source><year>2019</year><volume>68</volume><issue>7</issue><fpage>1098</fpage><lpage>1099</lpage><pub-id pub-id-type="doi">10.1093/cid/ciy668</pub-id><pub-id pub-id-type="pmid">30351351</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Raoult D. From whipple disease to <italic>Tropheryma </italic>whipplei infection. Clin Infect Dis. 2019;68(7):1098&#x02013;9.<pub-id pub-id-type="pmid">30351351</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>El-Abassi</surname><given-names>R</given-names></name><name><surname>Soliman</surname><given-names>MY</given-names></name><name><surname>Williams</surname><given-names>F</given-names></name><etal/></person-group><article-title>Whipple's disease</article-title><source>J Neurol Sci</source><year>2017</year><volume>377</volume><fpage>197</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1016/j.jns.2017.01.048</pub-id><pub-id pub-id-type="pmid">28477696</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">El-Abassi R, Soliman MY, Williams F, <italic>et al</italic>. Whipple&#x02019;s disease. J Neurol Sci. 2017;377:197&#x02013;206.<pub-id pub-id-type="pmid">28477696</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Fenollar</surname><given-names>F</given-names></name><name><surname>C&#x000e9;lard</surname><given-names>M</given-names></name><name><surname>Lagier</surname><given-names>JC</given-names></name><etal/></person-group><article-title><italic>Tropheryma whipplei</italic> endocarditis</article-title><source>Emerg Infect Dis</source><year>2013</year><volume>19</volume><issue>11</issue><fpage>1721</fpage><lpage>1730</lpage><pub-id pub-id-type="doi">10.3201/eid1911.121356</pub-id><pub-id pub-id-type="pmid">24207100</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Fenollar F, C&#x000e9;lard M, Lagier JC, <italic>et al</italic>. <italic>Tropheryma whipplei</italic> endocarditis. Emerg Infect Dis. 2013;19(11):1721&#x02013;30.<pub-id pub-id-type="pmid">24207100</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Lagier</surname><given-names>JC</given-names></name><name><surname>Fenollar</surname><given-names>F</given-names></name><name><surname>Raoult</surname><given-names>D</given-names></name></person-group><article-title>Acute infections caused by <italic>Tropheryma whipplei</italic></article-title><source>Future Microbiol</source><year>2017</year><volume>12</volume><fpage>247</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.2217/fmb-2017-0178</pub-id><pub-id pub-id-type="pmid">28262041</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Lagier JC, Fenollar F, Raoult D. Acute infections caused by <italic>Tropheryma whipplei</italic>. Future Microbiol. 2017;12:247&#x02013;54.<pub-id pub-id-type="pmid">28262041</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Touitou</surname><given-names>V</given-names></name><name><surname>Fenollar</surname><given-names>F</given-names></name><name><surname>Cassoux</surname><given-names>N</given-names></name><etal/></person-group><article-title>Ocular Whipple&#x02019;s disease: therapeutic strategy and long-term follow-up</article-title><source>Ophthalmology</source><year>2012</year><volume>119</volume><issue>7</issue><fpage>1465</fpage><lpage>1469</lpage><pub-id pub-id-type="doi">10.1016/j.ophtha.2012.01.024</pub-id><pub-id pub-id-type="pmid">22420960</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Touitou V, Fenollar F, Cassoux N, <italic>et al</italic>. Ocular Whipple&#x02019;s disease: therapeutic strategy and long-term follow-up. Ophthalmology. 2012;119(7):1465&#x02013;9.<pub-id pub-id-type="pmid">22420960</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Winberg</surname><given-names>CD</given-names></name><name><surname>Rose</surname><given-names>ME</given-names></name><name><surname>Rappaport</surname><given-names>H</given-names></name></person-group><article-title>Whipple's disease of the lung</article-title><source>Am J Med</source><year>1978</year><volume>65</volume><issue>5</issue><fpage>873</fpage><lpage>880</lpage><pub-id pub-id-type="doi">10.1016/0002-9343(78)90809-4</pub-id><pub-id pub-id-type="pmid">81613</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Winberg CD, Rose ME, Rappaport H. Whipple&#x02019;s disease of the lung. Am J Med. 1978;65(5):873&#x02013;80.<pub-id pub-id-type="pmid">81613</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>CA</given-names></name><name><surname>Egan</surname><given-names>M</given-names></name><name><surname>Rawlinson</surname><given-names>J</given-names></name></person-group><article-title>Whipple&#x02019;s disease presenting with lung involvement</article-title><source>Thorax</source><year>1996</year><volume>51</volume><issue>3</issue><fpage>343</fpage><lpage>344</lpage><pub-id pub-id-type="doi">10.1136/thx.51.3.343</pub-id><pub-id pub-id-type="pmid">8779149</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Kelly CA, Egan M, Rawlinson J. Whipple&#x02019;s disease presenting with lung involvement. Thorax. 1996;51(3):343&#x02013;4.<pub-id pub-id-type="pmid">8779149</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Fenollar</surname><given-names>F</given-names></name><name><surname>Ponge</surname><given-names>T</given-names></name><name><surname>La Scola</surname><given-names>B</given-names></name><etal/></person-group><article-title>First isolation of <italic>Tropheryma whipplei</italic> from bronchoalveolar fluid and clinical implications</article-title><source>J Infect</source><year>2012</year><volume>65</volume><issue>3</issue><fpage>275</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1016/j.jinf.2011.11.026</pub-id><pub-id pub-id-type="pmid">22172770</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Fenollar F, Ponge T, La Scola B, <italic>et al</italic>. First isolation of <italic>Tropheryma whipplei</italic> from bronchoalveolar fluid and clinical implications. J Infect. 2012;65(3):275&#x02013;8.<pub-id pub-id-type="pmid">22172770</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Stein</surname><given-names>A</given-names></name><name><surname>Doutchi</surname><given-names>M</given-names></name><name><surname>Fenollar</surname><given-names>F</given-names></name><etal/></person-group><article-title><italic>Tropheryma whipplei</italic> pneumonia in a patient with HIV-2 infection</article-title><source>Am J Respir Crit Care Med</source><year>2013</year><volume>188</volume><issue>8</issue><fpage>1036</fpage><lpage>1037</lpage><pub-id pub-id-type="doi">10.1164/rccm.201304-0692LE</pub-id><pub-id pub-id-type="pmid">24127807</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Stein A, Doutchi M, Fenollar F, <italic>et al</italic>. <italic>Tropheryma whipplei</italic> pneumonia in a patient with HIV-2 infection. Am J Respir Crit Care Med. 2013;188(8):1036&#x02013;7.<pub-id pub-id-type="pmid">24127807</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Xia</surname><given-names>D</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><etal/></person-group><article-title>Severe pneumonia caused by infection with <italic>Tropheryma whipplei</italic> complicated with <italic>Acinetobacter baumannii</italic> infection: a case report involving a young woman</article-title><source>Front Public Health</source><year>2021</year><volume>9</volume><fpage>729595</fpage><pub-id pub-id-type="doi">10.3389/fpubh.2021.729595</pub-id><pub-id pub-id-type="pmid">34760862</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Wang S, Xia D, Wu J, <italic>et al</italic>. Severe pneumonia caused by infection with <italic>Tropheryma whipplei</italic> complicated with <italic>Acinetobacter baumannii</italic> infection: a case report involving a young woman. Front Public Health. 2021;9:729595.<pub-id pub-id-type="pmid">34760862</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Case report: <italic>Tropheryma whipplei</italic> hide in an AIDS patient with pneumocystis pneumonia</article-title><source>Front Public Health</source><year>2021</year><volume>9</volume><fpage>663093</fpage><pub-id pub-id-type="doi">10.3389/fpubh.2021.663093</pub-id><pub-id pub-id-type="pmid">34485213</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Yan J, Zhang B, Zhang Z, <italic>et al</italic>. Case report: <italic>Tropheryma whipplei</italic> hide in an AIDS patient with pneumocystis pneumonia. Front Public Health. 2021;9:663093.<pub-id pub-id-type="pmid">34485213</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>B</given-names></name><name><surname>Tang</surname><given-names>J</given-names></name><name><surname>Fang</surname><given-names>R</given-names></name><etal/></person-group><article-title>Pulmonary coinfection of <italic>Mycobacterium tuberculosis</italic> and <italic>Tropheryma whipplei</italic>: a case report</article-title><source>J Med Case Rep</source><year>2021</year><volume>15</volume><issue>1</issue><fpage>359</fpage><pub-id pub-id-type="doi">10.1186/s13256-021-02899-y</pub-id><pub-id pub-id-type="pmid">34243811</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Zhu B, Tang J, Fang R, <italic>et al</italic>. Pulmonary coinfection of <italic>Mycobacterium tuberculosis</italic> and <italic>Tropheryma whipplei</italic>: a case report. J Med Case Rep. 2021;15(1):359.<pub-id pub-id-type="pmid">34243811</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Severe pneumonia in adults caused by <italic>Tropheryma whipplei</italic> and <italic>Candida</italic> sp. infection: a 2019 case series</article-title><source>BMC Pulm Med</source><year>2021</year><volume>21</volume><issue>1</issue><fpage>29</fpage><pub-id pub-id-type="doi">10.1186/s12890-020-01384-4</pub-id><pub-id pub-id-type="pmid">33451316</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Li W, Zhang Q, Xu Y, <italic>et al</italic>. Severe pneumonia in adults caused by <italic>Tropheryma whipplei</italic> and <italic>Candida</italic> sp. infection: a 2019 case series. BMC Pulm Med. 2021;21(1):29.<pub-id pub-id-type="pmid">33451316</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>WM</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name></person-group><article-title>Pulmonary parenchymal involvement caused by <italic>Tropheryma whipplei</italic></article-title><source>Open Med</source><year>2021</year><volume>16</volume><issue>1</issue><fpage>843</fpage><lpage>846</lpage><pub-id pub-id-type="doi">10.1515/med-2021-0297</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Zhang WM, Xu L. Pulmonary parenchymal involvement caused by <italic>Tropheryma whipplei</italic>. Open Med. 2021;16(1):843&#x02013;6.</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Dolmans</surname><given-names>RA</given-names></name><name><surname>Boel</surname><given-names>CH</given-names></name><name><surname>Lacle</surname><given-names>MM</given-names></name><etal/></person-group><article-title>Clinical manifestations, treatment, and diagnosis of <italic>Tropheryma whipplei</italic> infections</article-title><source>Clin Microbiol Rev</source><year>2017</year><volume>30</volume><issue>2</issue><fpage>529</fpage><lpage>555</lpage><pub-id pub-id-type="doi">10.1128/CMR.00033-16</pub-id><pub-id pub-id-type="pmid">28298472</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Dolmans RA, Boel CH, Lacle MM, <italic>et al</italic>. Clinical manifestations, treatment, and diagnosis of <italic>Tropheryma whipplei</italic> infections. Clin Microbiol Rev. 2017;30(2):529&#x02013;55.<pub-id pub-id-type="pmid">28298472</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Lagier</surname><given-names>JC</given-names></name><name><surname>Raoult</surname><given-names>D</given-names></name></person-group><article-title>Whipple's disease and <italic>Tropheryma whipplei</italic> infections: when to suspect them and how to diagnose and treat them</article-title><source>Curr Opin Infect Dis</source><year>2018</year><volume>31</volume><issue>6</issue><fpage>463</fpage><lpage>470</lpage><pub-id pub-id-type="doi">10.1097/QCO.0000000000000489</pub-id><pub-id pub-id-type="pmid">30299363</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Lagier JC, Raoult D. Whipple&#x02019;s disease and <italic>Tropheryma whipplei</italic> infections: when to suspect them and how to diagnose and treat them. Curr Opin Infect Dis. 2018;31(6):463&#x02013;70.<pub-id pub-id-type="pmid">30299363</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Tang</surname><given-names>J</given-names></name><etal/></person-group><article-title>The clinical application of metagenomic next-generation sequencing in immunocompromised patients with severe respiratory infections in the ICU</article-title><source>Respir Res</source><year>2024</year><volume>25</volume><issue>1</issue><fpage>360</fpage><pub-id pub-id-type="doi">10.1186/s12931-024-02991-z</pub-id><pub-id pub-id-type="pmid">39369191</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Zhao J, Sun Y, Tang J, <italic>et al</italic>. The clinical application of metagenomic next-generation sequencing in immunocompromised patients with severe respiratory infections in the ICU. Respir Res. 2024;25(1):360.<pub-id pub-id-type="pmid">39369191</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Diao</surname><given-names>Z</given-names></name><name><surname>Han</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><etal/></person-group><article-title>Metagenomics next-generation sequencing tests take the stage in the diagnosis of lower respiratory tract infections</article-title><source>J Adv Res</source><year>2022</year><volume>38</volume><fpage>201</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1016/j.jare.2021.09.012</pub-id><pub-id pub-id-type="pmid">35572406</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Diao Z, Han D, Zhang R, <italic>et al</italic>. Metagenomics next-generation sequencing tests take the stage in the diagnosis of lower respiratory tract infections. J Adv Res. 2022;38:201&#x02013;12.<pub-id pub-id-type="pmid">35572406</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Boumaza</surname><given-names>A</given-names></name><name><surname>Ben Azzouz</surname><given-names>E</given-names></name><name><surname>Arrindell</surname><given-names>J</given-names></name><etal/></person-group><article-title>Whipple's disease and <italic>Tropheryma whipplei</italic> infections: from bench to bedside</article-title><source>Lancet Infect Dis</source><year>2022</year><volume>22</volume><issue>10</issue><fpage>e280</fpage><lpage>e291</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(22)00128-1</pub-id><pub-id pub-id-type="pmid">35427488</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Boumaza A, Ben Azzouz E, Arrindell J, <italic>et al</italic>. Whipple&#x02019;s disease and <italic>Tropheryma whipplei</italic> infections: from bench to bedside. Lancet Infect Dis. 2022;22(10):e280&#x02013;91.<pub-id pub-id-type="pmid">35427488</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrieres</surname><given-names>L</given-names></name><name><surname>Laroche</surname><given-names>M</given-names></name><name><surname>Bonnet</surname><given-names>D</given-names></name><etal/></person-group><article-title>Whipple's disease: diagnosis and predictive factors of relapse</article-title><source>Eur J Gastroenterol Hepatol</source><year>2020</year><volume>32</volume><issue>3</issue><fpage>325</fpage><lpage>328</lpage><pub-id pub-id-type="doi">10.1097/MEG.0000000000001611</pub-id><pub-id pub-id-type="pmid">31764405</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Ferrieres L, Laroche M, Bonnet D, <italic>et al</italic>. Whipple&#x02019;s disease: diagnosis and predictive factors of relapse. Eur J Gastroenterol Hepatol. 2020;32(3):325&#x02013;8.<pub-id pub-id-type="pmid">31764405</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>